title: Current pharmacologic treatment of multiple sclerosis symptoms.
abstract: About 350,000 persons in the United States have multiple sclerosis, and primary care physicians are often called on to provide symptomatic therapy for these patients. We review our current pharmacologic approach to the management of multiple sclerosis exacerbations and the symptoms of spasticity, fatigue, bladder and bowel involvement, neurobehavioral complaints, pain syndromes, dystonic spasms, and tremor and ataxia.
authors.affiliation: University of California, San Francisco, School of Medicine (UCSF)-Mount Zion Multiple Sclerosis Center 94115, USA.
authors.forename: P B
authors.initials: PB
authors.lastname: Andersson
authors.forename: D E
authors.initials: DE
authors.lastname: Goodkin
mesh_terms: D003672:Defecation; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D005221:Fatigue / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000188:drug therapy / Q000209:etiology; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D014555:Urination Disorders / Q000188:drug therapy / Q000209:etiology